HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study.

Abstract
We used immunocytochemistry to identify ubiquitin and beta-amyloid-protein in muscle biopsies from patients with three neuromuscular disorders characterized by the presence of rimmed vacuoles in muscle fibres: inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy (OPMD). Labelling with anti-ubiquitin antibodies was observed in all three diseases, but it was frequent in IBM, less common in familial IBM-like disorder and rare in OPMD. This labelling is thought to correspond to the presence of IBM-type filaments (16-18 nm in external diameter) which are characteristic but not specific for IBM or familial IBM-like disorder, as they may also occur in other diseases including OPMD. Labelling with anti-beta-amyloid-protein antibody was seen in a few fibres in IBM but not in the other two conditions. The structures labelled with this antibody have yet to be determined. Labelling with anti-ubiquitin or anti-beta-amyloid-protein antibodies was not correlated with the presence of acid phosphatase activity.
AuthorsA Leclerc, F M Tomé, M Fardeau
JournalNeuromuscular disorders : NMD (Neuromuscul Disord) Vol. 3 Issue 4 Pg. 283-91 (Jul 1993) ISSN: 0960-8966 [Print] England
PMID8268725 (Publication Type: Journal Article)
Chemical References
  • Amyloid beta-Peptides
  • Ubiquitins
Topics
  • Adult
  • Aged
  • Amyloid beta-Peptides (analysis)
  • Child, Preschool
  • Female
  • Humans
  • Immunohistochemistry
  • Inclusion Bodies
  • Male
  • Middle Aged
  • Muscles (pathology)
  • Muscular Dystrophies (pathology)
  • Myositis (pathology)
  • Neuromuscular Diseases (pathology)
  • Ubiquitins (analysis)
  • Vacuoles (pathology, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: